Telomerase activity in plasma cell dyscrasias

被引:0
作者
D Xu
C Zheng
S Bergenbrant
G Holm
M Björkholm
Q Yi
A Gruber
机构
[1] Karolinska Hospital,Department of Medicine, Division of Hematology
[2] University of Arkansas for Medical Sciences,Myeloma and Transplantation Research Center
来源
British Journal of Cancer | 2001年 / 84卷
关键词
hTERT; multiple myeloma; plasma cells; telomerase;
D O I
暂无
中图分类号
学科分类号
摘要
Activation of telomerase is essential for in vitro cellular immortalization and tumorigenesis. In the present study, we investigated telomerase activation and its implications in plasma cell dyscrasias including monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM) and plasma cell leukaemia (PCL). All 5 patients with MGUS exhibited normal levels of telomerase activity in their plasma cells. Elevated telomerase activity was found in the samples from 21/27 patients with MM and 4/4 with PCL. In addition, 4 myeloma cell lines all expressed high levels of telomerase activity. The expression of telomerase reverse transcriptase (hTERT) and telomerase RNA template (hTER) was positively associated with the levels of telomerase activity in MM/PCL. Tankyrase expression was upregulated, concomitant with the induction of hTERT and activation of telomerase in MM/PCL. The present findings indicate that MGUS cells may not be immortalized and that activation of telomerase plays a role in the malignant transformation from MGUS to MM. © 2001 Cancer Research Campaign
引用
收藏
页码:621 / 625
页数:4
相关论文
共 50 条
  • [31] Comparison of laboratory methods for the detection of neoplastic plasma cells in plasma cell dyscrasias
    Dietz, Robin
    Lollie, Trang K.
    Goh, Tracie
    Rao, Nagesh
    Pullarkat, Sheeja
    JOURNAL OF CLINICAL PATHOLOGY, 2022, 75 (11) : 739 - 743
  • [32] Clinical and Biological Characteristics of Medullary and Extramedullary Plasma Cell Dyscrasias
    Janjetovic, Snjezana
    Lohneis, Philipp
    Nogai, Axel
    Balci, Derya
    Rasche, Leo
    Jahne, Doris
    Bokemeyer, Carsten
    Schilling, Georgia
    Blau, Igor Wolfgang
    Schmidt-Hieber, Martin
    BIOLOGY-BASEL, 2021, 10 (07):
  • [33] Magnetic resonance imaging of the spine in plasma cell dyscrasias - A review
    Pertuiset, E
    Bellaiche, L
    Liote, F
    Laredo, JD
    REVUE DU RHUMATISME, 1996, 63 (11): : 837 - 845
  • [34] Mutational landscape reflects the biological continuum of plasma cell dyscrasias
    Rossi, A.
    Voigtlaender, M.
    Janjetovic, S.
    Thiele, B.
    Alawi, M.
    Maerz, M.
    Brandt, A.
    Hansen, T.
    Radloff, J.
    Schoen, G.
    Hegenbart, U.
    Schoenland, S.
    Langer, C.
    Bokemeyer, C.
    Binder, M.
    BLOOD CANCER JOURNAL, 2017, 7 : e537 - e537
  • [35] A Rare Plasma Cell Dyscrasias: IgM Myeloma: Case Report
    Sonmez, Mehmet
    Cobanoglu, Umit
    Sonmez, Bircan
    Erkut, Nergiz
    Yilmaz, Mustafa
    Reis, A. Kadir
    Ovali, Ercument
    TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2010, 30 (05): : 1727 - 1731
  • [36] Soluble IL-6R in plasma cell dyscrasias
    Smith, SR
    Morgan, L
    LEUKEMIA & LYMPHOMA, 1997, 26 (5-6) : 489 - 495
  • [37] The Non-Coding RNA Landscape of Plasma Cell Dyscrasias
    Morelli, Eugenio
    Gulla, Annamaria
    Rocca, Roberta
    Federico, Cinzia
    Raimondi, Lavinia
    Malvestiti, Stefano
    Agosti, Valter
    Rossi, Marco
    Costa, Giosue
    Giavaresi, Gianluca
    Azab, Abdel Kareem
    Cagnetta, Antonia
    Cea, Michele
    Tagliaferri, Pierosandro
    Neri, Antonino
    Munshi, Nikhil C.
    Viglietto, Giuseppe
    Tassone, Pierfrancesco
    Amodio, Nicola
    CANCERS, 2020, 12 (02)
  • [38] Correlation of plasma cell assessment by phenotypic methods and molecular profiles by NGS in patients with plasma cell dyscrasias
    Ekaterina Rebmann Chigrinova
    Naomi A. Porret
    Martin Andres
    Gertrud Wiedemann
    Yara Banz
    Myriam Legros
    Matthias Pollak
    Elisabeth Oppliger Leibundgut
    Thomas Pabst
    Ulrike Bacher
    BMC Medical Genomics, 15
  • [39] Correlation of plasma cell assessment by phenotypic methods and molecular profiles by NGS in patients with plasma cell dyscrasias
    Chigrinova, Ekaterina Rebmann
    Porret, Naomi A.
    Andres, Martin
    Wiedemann, Gertrud
    Banz, Yara
    Legros, Myriam
    Pollak, Matthias
    Leibundgut, Elisabeth Oppliger
    Pabst, Thomas
    Bacher, Ulrike
    BMC MEDICAL GENOMICS, 2022, 15 (01)
  • [40] Elevated serum FGF23 concentrations in plasma cell dyscrasias
    Stewart, Inge
    Roddie, Claire
    Gill, Anthony
    Clarkson, Adele
    Mirams, Michiko
    Coyle, Luke
    Ward, Christopher
    Clifton-Bligh, Philip
    Robinson, Bruce G.
    Mason, Rebecca S.
    Clifton-Bligh, Roderick J.
    BONE, 2006, 39 (02) : 369 - 376